Ajovy

Ajovy

Manufacturer:

Vetter Pharma

Distributor:

DKLL

Marketer:

Teva Pharma
Concise Prescribing Info
Contents
Fremanezumab
Indications/Uses
Prophylaxis of migraine in adults w/ at least 4 migraine days/mth.
Dosage/Direction for Use
SC Inj into areas of the abdomen, thigh or upper arm. 225 mg once mthly or 675 mg every 3 mth.
Contraindications
Special Precautions
Do not administer by IV or IM. Discontinue administration if hypersensitivity reactions occur. Patients w/ certain major CV diseases. Avoid use during pregnancy. Lactation. Childn <18 yr.
Adverse Reactions
Inj site pain, induration & erythema. Inj site pruritus.
MIMS Class
Antimigraine Preparations
ATC Classification
N02CD03 - fremanezumab ; Belongs to the class of calcitonin gene-related peptide (CGRP) antagonists preparations. Used to relieve migraine.
Presentation/Packing
Form
Ajovy soln for inj 225 mg/1.5 mL
Packing/Price
1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in